Fisher and Paykel Healthcare

Auckland, New Zealand

Fisher and Paykel Healthcare

Auckland, New Zealand
SEARCH FILTERS
Time filter
Source Type

This report studies Respiratory Care Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering  ResMed  Philips Respironics  Covidien  Fisher and Paykel Healthcare  Maquet  CareFusion Corporation  Drager  Teleflex  DeVilbiss Healthcare(Drive Medical)  Invacare  Chart Industries  Weinmann  Inogen  Yuyue Medical  Masimo Corporation  Hamilton Medical  Nihon Kohden Corporation  Omron Healthcare  ACOMA  Heyer Medical Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Respiratory Care Devices in these regions, from 2011 to 2021 (forecast), like  North America  Europe  China  Japan  Southeast Asia  India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into  Therapeutic Device  Monitoring Device  Diagnostic Device Split by application, this report focuses on consumption, market share and growth rate of Respiratory Care Devices in each application, can be divided into  Household  Hospital  Application 3 1 Respiratory Care Devices Market Overview  1.1 Product Overview and Scope of Respiratory Care Devices  1.2 Respiratory Care Devices Segment by Type  1.2.1 Global Production Market Share of Respiratory Care Devices by Type in 2015  1.2.2 Therapeutic Device  1.2.3 Monitoring Device  1.2.4 Diagnostic Device  1.3 Respiratory Care Devices Segment by Application  1.3.1 Respiratory Care Devices Consumption Market Share by Application in 2015  1.3.2 Household  1.3.3 Hospital  1.3.4 Application 3  1.4 Respiratory Care Devices Market by Region  1.4.1 North America Status and Prospect (2011-2021)  1.4.2 Europe Status and Prospect (2011-2021)  1.4.3 China Status and Prospect (2011-2021)  1.4.4 Japan Status and Prospect (2011-2021)  1.4.5 Southeast Asia Status and Prospect (2011-2021)  1.4.6 India Status and Prospect (2011-2021)  1.5 Global Market Size (Value) of Respiratory Care Devices (2011-2021) 2 Global Respiratory Care Devices Market Competition by Manufacturers  2.1 Global Respiratory Care Devices Production and Share by Manufacturers (2015 and 2016)  2.2 Global Respiratory Care Devices Revenue and Share by Manufacturers (2015 and 2016)  2.3 Global Respiratory Care Devices Average Price by Manufacturers (2015 and 2016)  2.4 Manufacturers Respiratory Care Devices Manufacturing Base Distribution, Sales Area and Product Type  2.5 Respiratory Care Devices Market Competitive Situation and Trends  2.5.1 Respiratory Care Devices Market Concentration Rate  2.5.2 Respiratory Care Devices Market Share of Top 3 and Top 5 Manufacturers  2.5.3 Mergers & Acquisitions, Expansion 3 Global Respiratory Care Devices Production, Revenue (Value) by Region (2011-2016)  3.1 Global Respiratory Care Devices Production and Market Share by Region (2011-2016)  3.2 Global Respiratory Care Devices Revenue (Value) and Market Share by Region (2011-2016)  3.3 Global Respiratory Care Devices Production, Revenue, Price and Gross Margin (2011-2016)  3.4 North America Respiratory Care Devices Production, Revenue, Price and Gross Margin (2011-2016)  3.5 Europe Respiratory Care Devices Production, Revenue, Price and Gross Margin (2011-2016)  3.6 China Respiratory Care Devices Production, Revenue, Price and Gross Margin (2011-2016)  3.7 Japan Respiratory Care Devices Production, Revenue, Price and Gross Margin (2011-2016)  3.8 Southeast Asia Respiratory Care Devices Production, Revenue, Price and Gross Margin (2011-2016)  3.9 India Respiratory Care Devices Production, Revenue, Price and Gross Margin (2011-2016) 4 Global Respiratory Care Devices Supply (Production), Consumption, Export, Import by Regions (2011-2016)  4.1 Global Respiratory Care Devices Consumption by Regions (2011-2016)  4.2 North America Respiratory Care Devices Production, Consumption, Export, Import by Regions (2011-2016)  4.3 Europe Respiratory Care Devices Production, Consumption, Export, Import by Regions (2011-2016)  4.4 China Respiratory Care Devices Production, Consumption, Export, Import by Regions (2011-2016)  4.5 Japan Respiratory Care Devices Production, Consumption, Export, Import by Regions (2011-2016)  4.6 Southeast Asia Respiratory Care Devices Production, Consumption, Export, Import by Regions (2011-2016)  4.7 India Respiratory Care Devices Production, Consumption, Export, Import by Regions (2011-2016) 7 Global Respiratory Care Devices Manufacturers Profiles/Analysis  7.1 ResMed  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors  7.1.2 Respiratory Care Devices Product Type, Application and Specification  7.1.2.1 Type I  7.1.2.2 Type II  7.1.3 ResMed Respiratory Care Devices Production, Revenue, Price and Gross Margin (2015 and 2016)  7.1.4 Main Business/Business Overview  7.2 Philips Respironics  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors  7.2.2 Respiratory Care Devices Product Type, Application and Specification  7.2.2.1 Type I  7.2.2.2 Type II  7.2.3 Philips Respironics Respiratory Care Devices Production, Revenue, Price and Gross Margin (2015 and 2016)  7.2.4 Main Business/Business Overview  7.3 Covidien  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors  7.3.2 Respiratory Care Devices Product Type, Application and Specification  7.3.2.1 Type I  7.3.2.2 Type II  7.3.3 Covidien Respiratory Care Devices Production, Revenue, Price and Gross Margin (2015 and 2016)  7.3.4 Main Business/Business Overview  7.4 Fisher and Paykel Healthcare  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors  7.4.2 Respiratory Care Devices Product Type, Application and Specification  7.4.2.1 Type I  7.4.2.2 Type II  7.4.3 Fisher and Paykel Healthcare Respiratory Care Devices Production, Revenue, Price and Gross Margin (2015 and 2016)  7.4.4 Main Business/Business Overview  7.5 Maquet  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors  7.5.2 Respiratory Care Devices Product Type, Application and Specification  7.5.2.1 Type I  7.5.2.2 Type II


Respiratory care devices are the branch of medical devices focused on the treatment, management, control, diagnostic evaluation, and care of patients with abnormality in cardiopulmonary system. The devices are used in chronic obstructive pulmonary diseases (COPD), a degenerative lung diseases which primarily includes chronic bronchitis, and emphysema. The market is witnessing decent growth as COPD is one of the leading causes of death globally. By 2020, COPD is expected to be the fifth leading cause of death globally. The global respiratory care devices market is segmented on the basis of products and end users. Respiratory care devices products further segmented into diagnostic devices, therapeutic devices, and monitoring devices. Respiratory care diagnostic devices subcategorized into spirometers, polysomnography devices for sleep studies, and peak flow meters. The therapeutic devices segment is further divided into humidifiers, positive airway pressure (PAP) devices, nebulizers, and oxygen concentrators, inhalers, reusable resuscitators, ventilators, nitric oxide delivery units, masks, and oxygen hoods. The monitoring devices segment is categorized into pulse oximeters, gas analyzers, and capnographs. Based on end users, global respiratory care devices market further segmented into hospitals and home care. Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa, and Rest of the World. In product segment, respiratory therapeutic devices market accounted for largest share globally in 2014. Major driving factors for therapeutic devices market was increasing adoption to the various devices such as humidifiers, nebulizers, and oxygen concentrators due to increasing prevalence of respiratory diseases, and rising geriatric population. Hospitals respiratory care device market was major market as compared to home care due to financial capabilities of hospitals to purchase high cost devices is more. North America accounted the largest share of the market followed by Europe due to highly developed health care infrastructure, large pool of respiratory disease patients due to lifestyle such as smoking and tobacco habits, and availability of trained personnel to operate the advanced respiratory devices. However, Asia Pacific is expected to grow at the highest rate owing to increasing per capita income, and gradually developing health care infrastructure. Major driving factors for the global respiratory care devices market are rise in number of chronic pulmonary obstructive diseased patients, and continuous surge in numbers due to changing life style and environment such as increasing pollution level and smokers, rising geriatric population, new launching of the product coupled with strong pipeline of the product. In addition to that rise in demand for home care respiratory devices. According to Centers for Disease Control and Prevention (CDC), more than 16 million population in America were living with a diseases caused by smoking such as lung diseases, COPD, heart diseases, and cancer in 2014. Additionally, rising geriatric population is a major cause of driving the market. According to World Health Organization (WHO), more than 2 billion population will be aged 60 and older by 2050. However, lack of awareness in developing region, and some of the harmful effects of respiratory devices on neonates can restraint the market growth. Additionally, excise tax on devices by some countries would expect to impact the market negatively. Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/3683 Key players in the global respiratory care devices market are Philips Healthcare (Netherlands), Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), ResMed, Inc. (U.S.), Covidien plc (Ireland), and CareFusion Corporation (U.S.).


White D.E.,Auckland University of Technology | Al-Jumaily A.M.,Auckland University of Technology | Bartley J.,University of Auckland | Somervell A.,Fisher and Paykel Healthcare
Current Respiratory Medicine Reviews | Year: 2011

It has been reported that continuous positive airway pressure therapy introduces negative nasal side-effects including sneezing, itching, nasal dryness, nasal congestion and/or a runny nose. As these symptoms are suggestive of nasal dysfunction, heated humidification is often used to fully saturate and heat the inhaled air to core body temperature. It is expected that this relieves the nasal mucosa from having to supply, or recover, heat and moisture from inspired and expired air. This review summarizes the current in vitro and in vivo knowledge relevant to nasal air-conditioning, and identifies further investigations necessary to improve our understanding the changes that occur during nasal continuous positive airway pressure therapy. Investigations into nasal airway fluid transportation, airflow regulation and heat and fluid supply may lead to a therapy temperature/pressure/humidification algorithm that optimizes these parameters for a prescribed therapy pressure. Optimization could lead to a reduction in titration pressure and improved treatment compliance. © 2011 Bentham Science Publishers Ltd.


Parke R.L.,Auckland City Hospital | Eccleston M.L.,Auckland City Hospital | Eccleston M.L.,Fisher and Paykel Healthcare | McGuinness S.P.,Auckland City Hospital
Respiratory Care | Year: 2011

BACKGROUND: Nasal high-flow oxygen therapy increases the mean nasopharyngeal airway pressure in adults, but the relationship between flow and pressure is not well defined. OBJECTIVE: To determine the relationship between flow and pressure with the Optiflow nasal high-flow oxygen therapy system. METHODS: We invited patients scheduled for elective cardiac surgery to participate. Measurements were performed with nasal high-flow oxygen at flows of 30, 40, and 50 L/min, with the patient's mouth both open and closed. Pressures were recorded over one minute of breathing, and average flows were calculated via simple averaging. RESULTS: With the mouth closed, the mean ± SD airway pressures at 30, 40, and 50 L/min were 1.93 ± 1.25 cm H2O, 2.58 ± 1.54 cm H2O, and 3.31 ± 1.05 cm H2O, respectively. There was a positive linear relationship between flow and pressure. CONCLUSIONS: The mean nasopharyngeal pressure during nasal high-flow oxygen increases as flow increases. (Australian Clinical Trials Registry http://www.adhb.govt.nz/achicu/hot_2_airway_pressure.htm). © 2011 Daedalus Enterprises.


Mundel T.,Massey University | Feng S.,Fisher and Paykel Healthcare | Tatkov S.,Fisher and Paykel Healthcare | Schneider H.,Johns Hopkins University
Journal of Applied Physiology | Year: 2013

Nasal high flow (NHF) has been shown to increase expiratory pressure and reduce respiratory rate but the mechanisms involved remain unclear. Ten healthy participants [age, 22 ± 2 yr; body mass index (BMI), 24 ± 2 kg/m2] were recruited to determine ventilatory responses to NHF of air at 37°C and fully saturated with water. We conducted a randomized, controlled, cross-over study consisting of four separate ∼60-min visits, each 1 wk apart, to determine the effect of NHF on ventilation during wakefulness (NHF at 0, 15, 30, and 45 liters/min) and sleep (NHF at 0, 15, and 30 liters/min). In addition, a nasal cavity model was used to compare pressure/air-flow relationships of NHF and continuous positive airway pressure (CPAP) throughout simulated breathing. During wakefulness, NHF led to an increase in tidal volume from 0.7 ± 0.1 liter to 0.8 ± 0.2, 1.0 ± 0.2, and 1.3 ± 0.2 liters, and a reduction in respiratory rate (fR) from 16 ± 2 to 13 ± 3, 10 ± 3, and 8 ± 3 breaths/min (baseline to 15, 30, and 45 liters/min NHF, respectively; P < 0.01). In contrast, during sleep, NHF led to a ∼20% fall in minute ventilation due to a decrease in tidal volume and no change in fR. In the nasal cavity model, NHF increased expiratory but decreased inspiratory resistance depending on both the cannula size and the expiratory flow rate. The mechanisms of action for NHF differ from those of CPAP and are sleep/wake-state dependent. NHF may be utilized to increase tidal breathing during wakefulness and to relieve respiratory loads during sleep. Copyright © 2013 the American Physiological Society.


Moller W.,Comprehensive Pneumology Center | Moller W.,Helmholtz Center for Environmental Research | Celik G.,Comprehensive Pneumology Center | Celik G.,Helmholtz Center for Environmental Research | And 9 more authors.
Journal of Applied Physiology | Year: 2015

Recent studies showed that nasal high flow (NHF) with or without supplemental oxygen can assist ventilation of patients with chronic respiratory and sleep disorders. The hypothesis of this study was to test whether NHF can clear dead space in two different models of the upper nasal airways. The first was a simple tube model consisting of a nozzle to simulate the nasal valve area, connected to a cylindrical tube to simulate the nasal cavity. The second was a more complex anatomically representative upper airway model, constructed from segmented CT-scan images of a healthy volunteer. After filling the models with tracer gases, NHF was delivered at rates of 15, 30, and 45 l/min. The tracer gas clearance was determined using dynamic infrared CO2 spectroscopy and 81mKr-gas radioactive gamma camera imaging. There was a similar tracer-gas clearance characteristic in the tube model and the upper airway model: clearance half-times were below 1.0 s and decreased with increasing NHF rates. For both models, the anterior compartments demonstrated faster clearance levels (half-times < 0.5 s) and the posterior sections showed slower clearance (half-times < 1.0 s). Both imaging methods showed similar flow-dependent tracer-gas clearance in the models. For the anatomically based model, there was complete tracer-gas removal from the nasal cavities within 1.0 s. The level of clearance in the nasal cavities increased by 1.8 ml/s for every 1.0 l/min increase in the rate of NHF. The study has demonstrated the fast-occurring clearance of nasal cavities by NHF therapy, which is capable of reducing of dead space rebreathing. Copyright © 2015 the American Physiological Society.


Wiseguyreports.Com Adds “Self-contained breathing apparatus (SCBA) -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2022” To Its Research Database This report studies Self-contained breathing apparatus (SCBA) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Self-contained breathing apparatus (SCBA) in these regions, from 2011 to 2021 (forecast), like Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Oxygen Respirator Air Respirator Chemical Oxygen Respirator Split by application, this report focuses on consumption, market share and growth rate of Self-contained breathing apparatus (SCBA) in each application, can be divided into Oil?and?Gas? Industrial Pharmaceutical?&?Healthcare Others Global Self-contained breathing apparatus (SCBA) Market Research Report 2017 1 Self-contained breathing apparatus (SCBA) Market Overview 1.1 Product Overview and Scope of Self-contained breathing apparatus (SCBA) 1.2 Self-contained breathing apparatus (SCBA) Segment by Type 1.2.1 Global Production Market Share of Self-contained breathing apparatus (SCBA) by Type in 2015 1.2.2 Oxygen Respirator 1.2.3 Air Respirator 1.2.4 Chemical Oxygen Respirator 1.3 Self-contained breathing apparatus (SCBA) Segment by Application 1.3.1 Self-contained breathing apparatus (SCBA) Consumption Market Share by Application in 2015 1.3.2 Oil?and?Gas? 1.3.3 Industrial 1.3.4 Pharmaceutical?&?Healthcare 1.3.5 Others 1.4 Self-contained breathing apparatus (SCBA) Market by Region 1.4.1 North America Status and Prospect (2012-2022) 1.4.2 Europe Status and Prospect (2012-2022) 1.4.3 China Status and Prospect (2012-2022) 1.4.4 Japan Status and Prospect (2012-2022) 1.4.5 Southeast Asia Status and Prospect (2012-2022) 1.4.6 India Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Self-contained breathing apparatus (SCBA) (2012-2022) 7 Global Self-contained breathing apparatus (SCBA) Manufacturers Profiles/Analysis 7.1 ResMed 7.1.1 Company Basic Information, Manufacturing Base and Its Competitors 7.1.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.1.2.1 Oxygen Respirator 7.1.2.2 Air Respirator 7.1.3 ResMed Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.1.4 Main Business/Business Overview 7.2 Philips Respironics 7.2.1 Company Basic Information, Manufacturing Base and Its Competitors 7.2.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.2.2.1 Oxygen Respirator 7.2.2.2 Air Respirator 7.2.3 Philips Respironics Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.2.4 Main Business/Business Overview 7.3 Covidien 7.3.1 Company Basic Information, Manufacturing Base and Its Competitors 7.3.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.3.2.1 Oxygen Respirator 7.3.2.2 Air Respirator 7.3.3 Covidien Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.3.4 Main Business/Business Overview 7.4 Fisher and Paykel Healthcare 7.4.1 Company Basic Information, Manufacturing Base and Its Competitors 7.4.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.4.2.1 Oxygen Respirator 7.4.2.2 Air Respirator 7.4.3 Fisher and Paykel Healthcare Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.4.4 Main Business/Business Overview 7.5 Maquet 7.5.1 Company Basic Information, Manufacturing Base and Its Competitors 7.5.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.5.2.1 Oxygen Respirator 7.5.2.2 Air Respirator 7.5.3 Maquet Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.5.4 Main Business/Business Overview 7.6 CareFusion Corporation 7.6.1 Company Basic Information, Manufacturing Base and Its Competitors 7.6.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.6.2.1 Oxygen Respirator 7.6.2.2 Air Respirator 7.6.3 CareFusion Corporation Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.6.4 Main Business/Business Overview 7.7 Teleflex 7.7.1 Company Basic Information, Manufacturing Base and Its Competitors 7.7.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.7.2.1 Oxygen Respirator 7.7.2.2 Air Respirator 7.7.3 Teleflex Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.7.4 Main Business/Business Overview 7.8 DeVilbiss Healthcare(Drive Medical) 7.8.1 Company Basic Information, Manufacturing Base and Its Competitors 7.8.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.8.2.1 Oxygen Respirator 7.8.2.2 Air Respirator 7.8.3 DeVilbiss Healthcare(Drive Medical) Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.8.4 Main Business/Business Overview 7.9 Invacare 7.9.1 Company Basic Information, Manufacturing Base and Its Competitors 7.9.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.9.2.1 Oxygen Respirator 7.9.2.2 Air Respirator 7.9.3 Invacare Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.9.4 Main Business/Business Overview 7.10 Drager USA 7.10.1 Company Basic Information, Manufacturing Base and Its Competitors 7.10.2 Self-contained breathing apparatus (SCBA) Product Type, Application and Specification 7.10.2.1 Oxygen Respirator 7.10.2.2 Air Respirator 7.10.3 Drager USA Self-contained breathing apparatus (SCBA) Production, Revenue, Price and Gross Margin (2015 and 2016) 7.10.4 Main Business/Business Overview For more information, please visit https://www.wiseguyreports.com/sample-request/996041-global-self-contained-breathing-apparatus-scba-market-research-report-2017


This report studies sales (consumption) of Self Contained Breathing Apparatus (SCBA) in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Self Contained Breathing Apparatus (SCBA) in these regions, from 2011 to 2021 (forecast), like Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Oxygen Respirator Air Respirator Chemical Oxygen Respirator Split by applications, this report focuses on sales, market share and growth rate of Self Contained Breathing Apparatus (SCBA) in each application, can be divided into Chemical Industry Electronic Industry Fire Protection Sector Other Industries Global Self Contained Breathing Apparatus (SCBA) Sales Market Report 2017 1 Self Contained Breathing Apparatus (SCBA) Overview 1.1 Product Overview and Scope of Self Contained Breathing Apparatus (SCBA) 1.2 Classification of Self Contained Breathing Apparatus (SCBA) 1.2.1 Oxygen Respirator 1.2.2 Air Respirator 1.2.3 Chemical Oxygen Respirator 1.3 Application of Self Contained Breathing Apparatus (SCBA) 1.3.1 Chemical Industry 1.3.2 Electronic Industry 1.3.3 Fire Protection Sector 1.3.4 Other Industries 1.4 Self Contained Breathing Apparatus (SCBA) Market by Regions 1.4.1 United States Status and Prospect (2011-2021) 1.4.2 China Status and Prospect (2011-2021) 1.4.3 Europe Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.4.5 Southeast Asia Status and Prospect (2011-2021) 1.4.6 India Status and Prospect (2011-2021) 1.5 Global Market Size (Value and Volume) of Self Contained Breathing Apparatus (SCBA) (2011-2021) 1.5.1 Global Self Contained Breathing Apparatus (SCBA) Sales and Growth Rate (2011-2021) 1.5.2 Global Self Contained Breathing Apparatus (SCBA) Revenue and Growth Rate (2011-2021) 9 Global Self Contained Breathing Apparatus (SCBA) Manufacturers Analysis 9.1 ResMed 9.1.1 Company Basic Information, Manufacturing Base and Competitors 9.1.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.1.2.1 Oxygen Respirator 9.1.2.2 Air Respirator 9.1.3 ResMed Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.1.4 Main Business/Business Overview 9.2 Philips Respironics 9.2.1 Company Basic Information, Manufacturing Base and Competitors 9.2.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.2.2.1 Oxygen Respirator 9.2.2.2 Air Respirator 9.2.3 Philips Respironics Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.2.4 Main Business/Business Overview 9.3 Covidien 9.3.1 Company Basic Information, Manufacturing Base and Competitors 9.3.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.3.2.1 Oxygen Respirator 9.3.2.2 Air Respirator 9.3.3 Covidien Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.3.4 Main Business/Business Overview 9.4 Fisher and Paykel Healthcare 9.4.1 Company Basic Information, Manufacturing Base and Competitors 9.4.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.4.2.1 Oxygen Respirator 9.4.2.2 Air Respirator 9.4.3 Fisher and Paykel Healthcare Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.4.4 Main Business/Business Overview 9.5 Maquet 9.5.1 Company Basic Information, Manufacturing Base and Competitors 9.5.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.5.2.1 Oxygen Respirator 9.5.2.2 Air Respirator 9.5.3 Maquet Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.5.4 Main Business/Business Overview 9.6 CareFusion Corporation 9.6.1 Company Basic Information, Manufacturing Base and Competitors 9.6.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.6.2.1 Oxygen Respirator 9.6.2.2 Air Respirator 9.6.3 CareFusion Corporation Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.6.4 Main Business/Business Overview 9.7 Teleflex 9.7.1 Company Basic Information, Manufacturing Base and Competitors 9.7.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.7.2.1 Oxygen Respirator 9.7.2.2 Air Respirator 9.7.3 Teleflex Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.7.4 Main Business/Business Overview 9.8 DeVilbiss Healthcare(Drive Medical) 9.8.1 Company Basic Information, Manufacturing Base and Competitors 9.8.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.8.2.1 Oxygen Respirator 9.8.2.2 Air Respirator 9.8.3 DeVilbiss Healthcare(Drive Medical) Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.8.4 Main Business/Business Overview 9.9 Invacare 9.9.1 Company Basic Information, Manufacturing Base and Competitors 9.9.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.9.2.1 Oxygen Respirator 9.9.2.2 Air Respirator 9.9.3 Invacare Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.9.4 Main Business/Business Overview 9.10 Drager USA 9.10.1 Company Basic Information, Manufacturing Base and Competitors 9.10.2 Self Contained Breathing Apparatus (SCBA) Product Type, Application and Specification 9.10.2.1 Oxygen Respirator 9.10.2.2 Air Respirator 9.10.3 Drager USA Self Contained Breathing Apparatus (SCBA) Sales, Revenue, Price and Gross Margin (2011-2016) 9.10.4 Main Business/Business Overview For more information, please visit https://www.wiseguyreports.com/sample-request/893721-global-self-contained-breathing-apparatus-scba-sales-market-report-2017


Tatkov S.,Massey University | Tatkov S.,Fisher and Paykel Healthcare | Pack R.J.,Massey University
Respiratory Care | Year: 2011

BACKGROUND: The efficacy of symmetrical-waveform high-frequency oscillating (HFO) air flow for airway secretion clearance is controversial and debated in the literature. METHODS: We conducted in vitro experiments with ovine tracheae to investigate the effects of symmetrical-waveform HFO on tracheal transport of artificial mucus. We mounted each trachea as an intact tube, with a 15° head-down tilt, infused artificial mucus (10 mL over one hour) at the caudal end of the trachea, and measured mucus-transport velocity as the time between the beginning of infusion and the first appearance of artificial mucus over 2 near-infrared sensors at the rostral end of the trachea and by measuring the amount of mucus emerging. In a second series of experiments we opened each trachea flat and with video microscopy we measured the transport velocity of plaques over the endogenous mucus sheet. RESULTS:In the intact-trachea preparation, HFOat20Hzand50cmH2O increased mucus-transport velocity from 5.8 mm/min to 7.8 mm/min. HFO led to nearly half the artificial mucus being cleared during the infusion period. In the opened-trachea experiments the mean control transport velocity was 8.7 mm/min, and HFO, at 14 Hz or 20 Hz (and 50 cm H2O), did not significantly alter that velocity. CONCLUSIONS: Symmetrical-waveform HFO increases mucus-transport velocity and mucus clearance when a thick layer of mucus is present. This may be important when considering the mechanisms of mucus clearance and using HFO for secretion clearance. © 2011 Daedalus Enterprises.


Hart D.E.,Middlemore Hospital | Forman M.,Fisher and Paykel Healthcare | Veale A.G.,Middlemore Hospital
Sleep and Breathing | Year: 2011

Rationale: Water condensate in the humidifier tubing can affect bi-level ventilation by narrowing tube diameter and increasing airflow resistance. We investigated room temperature and tubing type as ways to reduce condensate and its effect on bi-level triggering and pressure delivery. In this bench study, the aim was to test the hypothesis that a relationship exists between room temperature and tubing condensate. Methods: Using a patient simulator, a Res-med bi-level device was set to 18/8 cm H 2O and run for 6 h at room temperatures of 16°C, 18°C and 20°C. The built-in humidifier was set to a low, medium or high setting while using unheated or insulated tubing or replaced with a humidifier using heated tubing. Humidifier output, condensate, mask pressure and triggering delay of the bi-level were measured at 1 and 6 h using an infrared hygrometer, metric weights, Honeywell pressure transducer and TSI pneumotach. Results: When humidity output exceeded 17.5 mg H 2O/L, inspiratory pressure fell by 2-15 cm H 2O and triggering was delayed by 0.2-0.9 s. Heating the tubing avoided any such ventilatory effect whereas warmer room temperatures or insulating the tubing were of marginal benefit. Conclusions: Users of bi-level ventilators need to be aware of this problem and its solution. Bi-level humidifier tubing may need to be heated to ensure correct humidification, pressure delivery and triggering. © 2010 Springer-Verlag.

Loading Fisher and Paykel Healthcare collaborators
Loading Fisher and Paykel Healthcare collaborators